In a pair of randomized, observer-blinded clinical trials designed to evaluate optimal management of asymptomatic carotid ...

Healionics Corporation, a developer of synthetic biomaterial-based medical devices, announced recently that 24-month clinical ...

Imperative Care, Inc. announced late-breaking, real-world data from a multicenter review of 124 consecutive ischemic stroke ...

Okami Medical, Inc., a developer of vascular embolization solutions, announced that Drew Hykes was appointed President and ...

Pathfinder Medical, a United Kingdom-based developer of minimally invasive vascular access technologies, announced the appoint ...

Humacyte, Inc. announced that multiple presentations on the company’s acellular tissue-engineered vessel (ATEV) were del ...

AI-Stroke, a France-based Software-as-a-Medical-Device (SaMD) company using artificial intelligence (AI) to develop an “ ...

We spoke with Dr. Smuclovisky about his approach to treating chronic lower extremity venous thrombosis and his use of the ...

With the Sublime™ Microcatheter, I’ve found excellent balance between push, flexibility, and torqueability. I find it handles ...

AD, its design and what makes it unique, how funding was obtained, the role of the patient advocacy group, and more.

The aortic arch has long been considered the final frontier of endovascular therapy. The pace of innovation has accelerated ...

Specialists identify the key areas poised to shape the future of radial access across peripheral artery disease, ...